Skip to main content

Table 1 Patient baseline characteristics

From: Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial

Baseline characteristic

(n = 43)

Age, years

 

  18–44

10

  45–64

15

  ≥ 65

18

  Mean ± SD

56.5 (± 18.5)

  Range

19–91

Gender, % of patients

 

  Male

53.5

  Female

46.5

Race, n (%)

 

  Asian

43 (100)

Weighta, kg

 

  Mean ± SD

57.5 (± 12.2)

  Range

32.0–84.0

Heightb, cm

 

  Mean ± SD

162.4 (± 7.4)

  Range

148.0–180.0

Baseline pathogenc, n (%)

 

  Candida tropicalis

18 (41.9)

  C. albicans

14 (32.6)

  C. glabrata

6 (14.0)

  C. parapsilosis

4 (9.3)

  C. rugosa

1 (2.3)

  No pathogen isolated

1 (2.3)

  1. aData available from 41 patients.
  2. bData available from 38 patients.
  3. cPatients could have more than one pathogen isolated at baseline.
  4. Abbreviation used: SD, standard deviation.